Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reviews in Endocrine and Metabolic Disorders
Literature
1.
Koch CA, Pacak K, Chrousos GP. Endocrine tumors. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 1135–67. doi:10.​13140/​2.​1.​3053.​9845.
2.
Sarlis NJ. Expression patterns of cellular growth-controlling genes in non-medullary thyroid cancer: basic aspects. Rev Endocr Metab Disord. 2000;1(3):183–96.CrossRefPubMed
3.
Newman BD, Maher JF, Subauste JS, Uwaifo GI, Bigler SA, Koch CA. Clustering of sebaceous gland carcinoma, papillary thyroid carcinoma and breast cancer in a woman as a new cancer susceptibility disorder: a case report. J Med Case Rep. 2009;3:6905.CrossRefPubMedPubMedCentral
4.
Benvenga S, Antonelli A, Vita R. Thyroid nodules and thyroid autoimmunity in the context of environmental pollution. Rev Endocr Metab Disord. 2015;16:319–40.CrossRefPubMed
5.
6.
Benvenga S. On the association between Hashimoto’s thyroiditis and papillary thyroid carcinoma: looking 100 years back, and hopefully, fewer years ahead to sort out this association. Thyroid. 2013;23(9):1180–1.CrossRefPubMed
7.
Latina A, Gullo D, Trimarchi F, Benvenga S. Hashimoto’s thyroiditis: similar and dissimilar characteristics in neighboring areas. Possible implications for the epidemiology of thyroid cancer. PLoS ONE. 2013;8(3):e55450.CrossRefPubMedPubMedCentral
8.
Duntas LH, Doumas C. The rings of fire and thyroid cancer. Hormones (Athens). 2009;8(4):249–53.CrossRef
9.
Mokdad AH, Dwyer-Lindgren L, Fitzmaurice C, Stubbs RW, Bertozzi-Villa A, Morozoff C, et al. Trends and patterns of disparities in cancer mortality among US counties, 198–2014. JAMA. 2017;317(4):388–406.CrossRefPubMed
10.
11.
Burke DA. Atomic testing in Mississippi. Project Dribble and the Quest for Nuclear Weapons Treaty Verification in the Cold War Era. 216 pages, LSU Press, 1st edition; 2012. ISBN-10: 0807145831; ISBN-13: 978–0807145838.
12.
Nikiforov Y, Gnepp DR, Fagin JA. Thyroid lesions in children and adolescents after the Chernobyl disaster: implications for the study of radiation tumorigenesis. J Clin Endocrinol Metab. 1996;81(1):9–14.PubMed
13.
Agate L, Mariotti S, Elisei R, Mossa P, Pacini F, Molinaro E, et al. Thyroid autoantibodies and thyroid function in subjects exposed to Chernobyl fallout during childhood: evidence for a transient radiation-induced elevation of serum thyroid antibodies without an increase in thyroid autoimmune disease. J Clin Endocrinol Metab. 2008;93(7):2729–36.CrossRefPubMed
14.
Furukawa K, Preston D, Funamoto S, Yonehara S, Ito M, Tokuoka S, et al. Long-term trend of thyroid cancer risk among Japanese atomic-bomb survivors: 60 years after exposure. Int J Cancer. 2013;132(5):1222–6.CrossRefPubMed
15.
Gilbert ES, Huang L, Bouvilee A, Berg CD, Ron E. Thyroid cancer rates and 131I doses from Nevada atmospheric nuclear bomb tests: an update. Radiat Res. 2010;173(5):659–64.CrossRefPubMed
16.
Taira Y, Hayashida N, Yamaguchi H, Yamashita S, Endo Y, Takamura N. Evaluation of environmental contamination and estimated radiation doses for the return to residents’ homes in Kawauchi Village, Fukushima prefecture. PLoS ONE. 2012;7(9):e45816.CrossRefPubMedPubMedCentral
17.
Greenberg M, Lowrie K, Burger J, Powers C, Gochfeld M, Mayer H. Nuclear waste and public worries: public perceptions of the United States’ major nuclear weapons legacy sites. Hum Ecol Rev. 2007;14(1):1–12.
18.
Leeman-Neill RJ, Brenner AV, Little MP, Bogdanova TI, Hatch M, Zurnadzy LY, et al. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Cancer. 2013;119(10):1792–9.CrossRefPubMedPubMedCentral
19.
Leeman-Neill RJ, Kelly LM, Liu P, Brenner AV, Little MP, Bogdanova TI, et al. ETV6-NTRK3 is a common chromosomal rearrangement in radiation-associated thyroid cancer. Cancer. 2014;120(6):799–807.CrossRefPubMed
20.
Hamatani K, Eguchi H, Koyama K, Mukai M, Nakachi K, Kusunoki Y. A novel RET rearrangement (ACBD5/RET) by pericentric inversion, inv(10)(p12.1;q11.2), in papillary thyroid cancer from an atomic bomb survivor exposed to high-dose radiation. Oncol Rep. 2014;32(5):1809–14.PubMed
21.
Ieni A, Barresi V, Cardia R, Licata L, Di Bari F, Benvenga S, et al. The micropapillary/hobnail variant of papillary thyroid carcinoma: a review of series described in the literature compared to a series from Southern Italy pathology institution. Rev Endocr Metab Disord. 2016. doi:10.​1007/​s11154-016-9398-4
Metadata
Title
Editorial: A journey from brain to muscle across the thyroid continent
Author
Christian A. Koch
Publication date
01-12-2016
Publisher
Springer US
Published in
Reviews in Endocrine and Metabolic Disorders / Issue 4/2016
Print ISSN: 1389-9155
Electronic ISSN: 1573-2606
DOI
https://doi.org/10.1007/s11154-017-9413-4

Other articles of this Issue 4/2016

Reviews in Endocrine and Metabolic Disorders 4/2016 Go to the issue

EditorialNotes

A journey from brain to muscle across the thyroid continent

ReviewPaper

Advances in TRH signaling

ReviewPaper

Hypothyroid myopathy: A peculiar clinical presentation of thyroid failure. Review of the literature

ReviewPaper

Access, availability, and infrastructure deficiency: The current management of thyroid disease in the developing world

ReviewPaper

Molecular mimicry and autoimmune thyroid disease

ReviewPaper

Inositol(s) in thyroid function, growth and autoimmunity
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits